Xeno Financial Statements From 2010 to 2026

XENO Stock  USD 0.0001  0.00  0.00%   
Xeno Transplants' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Xeno Transplants' valuation are provided below:
Market Capitalization
64.6 K
We have found seventy-two available fundamental gauges for Xeno Transplants, which can be analyzed and compared to other ratios and to its peers. Self-guided Investors are advised to confirm Xeno Transplants' prevalent fundamentals against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. As of the 5th of February 2026, Market Cap is likely to grow to about 37.5 M. Also, Enterprise Value is likely to grow to about 37.5 M
Check Xeno Transplants financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xeno Transplants' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 166.3 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 97.23. Xeno financial statements analysis is a perfect complement when working with Xeno Transplants Valuation or Volatility modules.
  
Build AI portfolio with Xeno Stock
Check out the analysis of Xeno Transplants Correlation against competitors.
To learn how to invest in Xeno Stock, please use our How to Invest in Xeno Transplants guide.

Xeno Transplants Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets774.5 K737.6 K617.2 K
Slightly volatile
Total Current Liabilities359.4 K342.2 K287.1 K
Slightly volatile
Accounts Payable15.6 K17.2 K15.1 K
Slightly volatile
Cash38.8 K36.9 K30.9 K
Slightly volatile
Total Liabilities147.8 K293.7 K237.1 K
Pretty Stable
Total Current Assets2.4 K2.3 K1.9 K
Slightly volatile
Common Stock37.8 K68.5 K55.9 K
Slightly volatile
Property Plant Equipment614691754
Slightly volatile
Other Current Assets4.6 K5.2 K5.6 K
Slightly volatile
Short and Long Term Debt17.2 K19.4 K21.2 K
Slightly volatile
Short Term Debt17.2 K19.4 K21.2 K
Slightly volatile
Intangible Assets482.9 K543.2 K592.9 K
Slightly volatile

Xeno Transplants Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative166.3 K294 K240.4 K
Slightly volatile

Xeno Transplants Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock30.4 K42.3 K35.7 K
Slightly volatile
Net Borrowings28.9 K30.4 K49.8 K
Slightly volatile
Depreciation282318347
Slightly volatile
Total Cash From Financing Activities67.5 K71 K92.7 K
Slightly volatile
Change To Netincome574800675
Slightly volatile
Change To Liabilities31.5 K50.6 K41.9 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
PTB Ratio97.2392.697.058
Slightly volatile
Book Value Per Share0.0110.01050.0112
Slightly volatile
Capex To Depreciation2.542.863.1197
Slightly volatile
PB Ratio97.2392.697.058
Slightly volatile
ROIC0.40.380.3754
Slightly volatile
Cash Per Share0.00190.00110.0012
Slightly volatile
Interest Coverage156175191
Slightly volatile
Income Quality1.011.161.0272
Very volatile
Net Debt To EBITDA0.410.290.2972
Slightly volatile
Current Ratio0.140.130.138
Slightly volatile
Tangible Book Value Per Share0.0110.01050.0112
Slightly volatile
Shareholders Equity Per Share0.0110.01050.0112
Slightly volatile
Capex Per Share0.01210.01150.0119
Slightly volatile
Interest Debt Per Share0.00.00.0
Slightly volatile
Price Book Value Ratio97.2392.697.058
Slightly volatile
Return On Capital Employed0.40.380.3754
Slightly volatile
Quick Ratio0.140.130.138
Slightly volatile
Cash Ratio0.120.110.1172
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio2.143.863.9483
Very volatile
Price To Book Ratio97.2392.697.058
Slightly volatile
Price Fair Value97.2392.697.058
Slightly volatile

Xeno Transplants Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap37.5 M35.7 M37.1 M
Slightly volatile
Enterprise Value37.5 M35.7 M37 M
Slightly volatile

About Xeno Transplants Financial Statements

Xeno Transplants investors utilize fundamental indicators, such as revenue or net income, to predict how Xeno Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year

Pair Trading with Xeno Transplants

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xeno Transplants position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeno Transplants will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Xeno Transplants could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xeno Transplants when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xeno Transplants - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xeno Transplants to buy it.
The correlation of Xeno Transplants is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xeno Transplants moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xeno Transplants moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xeno Transplants can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Xeno Transplants offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xeno Transplants' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xeno Transplants Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xeno Transplants Stock:
Check out the analysis of Xeno Transplants Correlation against competitors.
To learn how to invest in Xeno Stock, please use our How to Invest in Xeno Transplants guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Will Biotechnology sector continue expanding? Could Xeno diversify its offerings? Factors like these will boost the valuation of Xeno Transplants. Anticipated expansion of Xeno directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Xeno Transplants data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Understanding Xeno Transplants requires distinguishing between market price and book value, where the latter reflects Xeno's accounting equity. The concept of intrinsic value - what Xeno Transplants' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Xeno Transplants' price substantially above or below its fundamental value.
Please note, there is a significant difference between Xeno Transplants' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xeno Transplants is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Xeno Transplants' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.